International Myeloma Workshop 2021 | Daily Update, Part 1 | Newly Diagnosed + MRD

Did you find this video helpful? If so, please let us know via the survey below:
www.surveymonkey.com/r/MMRF20...
Mary DeRome, Director of Medical Communications and Education at the Multiple Myeloma Research Foundation, speaks with Dr. Melissa Alsina, Associate Member of Blood & Marrow Transplantation and Cellular Immunotherapy and Head of the Multiple Myeloma Program at the Moffitt Cancer Center in Tampa, Florida, and Dr. Shaji Kumar, Mark and Judy Mullins Professor of Hematological Malignancies at the Mayo Clinic in Rochester, Minnesota.
Dr. Alsina and Dr. Kumar provide insights on the key takeaways for patients from the first day of presentations at the International Myeloma Workshop (IMW) 2021 meeting. The presentations focused on newly diagnosed multiple myeloma (including diagnostic testing, treatments for transplant ineligible patients, and maintenance therapy), minimal residual disease measurement, and the newest treatment on the horizon: iberdomide.
Daily updates from IMW 2021 are supported by GlaxoSmithKline, Janssen, Karyopharm, and Oncopeptides. Please visit the Virtual Exhibit Hall for more information from our sponsors. themmrf.org/resources/educati...
For more information on our patient education program and events please visit: themmrf.org/resources/educati...
If you have additional questions about what you watched, please call our MMRF Patient Navigation Center at 1-888-841-6673.

[@CancerResearchDemystified]

Thanks for posting this! Looking forward to future updates!